DrugPatentWatch Database Preview
Amag Pharma Usa Company Profile
What is the competitive landscape for AMAG PHARMA USA, and when can generic versions of AMAG PHARMA USA drugs launch?
There are eight US patents protecting AMAG PHARMA USA drugs.
There are forty-one patent family members on AMAG PHARMA USA drugs in twelve countries.
Summary for Amag Pharma Usa
| International Patents: | 41 |
| US Patents: | 8 |
| Tradenames: | 3 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Amag Pharma Usa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amag Pharma Usa | MAKENA (AUTOINJECTOR) | hydroxyprogesterone caproate | SOLUTION;SUBCUTANEOUS | 021945-004 | Feb 14, 2018 | RX | Yes | Yes | 9,789,257 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Amag Pharma Usa | MAKENA (AUTOINJECTOR) | hydroxyprogesterone caproate | SOLUTION;SUBCUTANEOUS | 021945-004 | Feb 14, 2018 | RX | Yes | Yes | RE44846 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Amag Pharma Usa | MAKENA PRESERVATIVE FREE | hydroxyprogesterone caproate | SOLUTION;INTRAMUSCULAR | 021945-002 | Feb 19, 2016 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Amag Pharma Usa | MAKENA (AUTOINJECTOR) | hydroxyprogesterone caproate | SOLUTION;SUBCUTANEOUS | 021945-004 | Feb 14, 2018 | RX | Yes | Yes | 9,180,259 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Non-Orange Book US Patents for Amag Pharma Usa
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 9,446,195 | Injection device with cammed ram assembly | ➤ Sign Up |
| RE44847 | Needle assisted jet injector | ➤ Sign Up |
| 6,428,528 | Needle assisted jet injector | ➤ Sign Up |
| 8,496,619 | Injection device with cammed ram assembly | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Amag Pharma Usa Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Canada | 2900672 | ➤ Sign Up |
| European Patent Office | 2953667 | ➤ Sign Up |
| European Patent Office | 1104317 | ➤ Sign Up |
| Australia | 2013203784 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
